Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
15%

OVERLAP
BY WEIGHT
11

# OF OVERLAPPING
HOLDINGS
SBIO
79
HOLDINGS
16%
ALSO IN IBRN
IBRN
58
HOLDINGS
29%
ALSO IN SBIO
SECTOR DRIFT (SBIO minus IBRN)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in SBIO
Weight
in IBRN
Overlap
ALKERMES PLC 3.7% 4.8% 3.7%
ACADIA PHARMACEUTICALS INC 2.6% 3.5% 2.6%
DENALI THERAPEUTICS INC. 2.0% 3.7% 2.0%
EDGEWISE THERAPEUTICS, INC. 2.0% 3.0% 2.0%
DIANTHUS THERAPEUTICS INC 1.4% 2.4% 1.4%
SBIO Overweight Relative to IBRN
KYMERA THERAPEUTICS, INC. 4.1%
MIRUM PHARMACEUTICALS, INC. 3.3%
CELCUITY INC. 3.2%
AMICUS THERAPEUTICS INC 2.9%
CRINETICS PHARMACEUTICALS INC 2.8%
CG ONCOLOGY, INC. 2.6%
APOGEE THERAPEUTICS, INC. 2.2%
VIKING THERAPEUTICS, INC. 2.1%
DISC MEDICINE, INC. 2.0%
APELLIS PHARMACEUTICALS, INC. 1.9%
SBIO Underweight Relative to IBRN
AXSOME THERAPEUTICS, INC. -4.9%
BIOGEN IDEC INC -4.5%
SCHOLAR ROCK HOLDING CORP. -4.3%
PTC THERAPEUTICS INC -3.9%
SUPERNUS PHARMACEUTICALS INC -3.7%
NEUROCRINE BIOSCIENCES INC -3.7%
ARGENX SE ADR -3.6%
CATALYST PHARMACEUTICAL PART -3.6%
SK BIOPHARMACEUTICALS CO., LTD. -2.8%
DYNE THERAPEUTICS INC -2.3%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY